According to the global nucleotides market report by IMARC Group, the market reached a value of US$ 667.0 Million in 2022, and it is projected to reach a value of US$ 995.3 Million by 2028, exhibiting a CAGR of 6.7% during 2023-2028.
Nucleotides represent organic molecules consisting of a phosphate and a nucleoside that form the basic building block of nucleic acids, including deoxyribonucleic acid (DNA) and ribonucleic acid (RNA).
They can be categorized into various types, such as food grade, lab grade, industry grade, etc. These nucleotides improve several metabolic processes and aid in the formation of the protein structures synthesized in the cell. They even act with enzymes to accelerate biochemical reactions in the body, assist in the biosynthesis of macromolecules, aid in encoding, transmitting, and expressing genetic information in the body, and provide a high degree of selectivity and potency against the herpes group of viruses. As a result, nucleotides find extensive applications across numerous sectors, including pharmaceuticals, nutraceuticals, food, dairy, animal feed additives, etc.
Request For Sample Report: https://www.imarcgroup.com/nucleotides-market/requestsample
Market Trends & Drivers
The rising employment of nucleotide supplements in dairy products, such as powdered milk, yogurt, condensed milk, etc., is primarily driving the nucleotides market. Moreover, the escalating availability of the product in the form of powdered fluids is acting as another significant growth-inducing factor.Apart from this, the increasing adoption of these supplements in nutraceuticals segment to treat stress, poor nutrition, and hypertension and in diagnostic research for diagnosing the presence of viral ailments and types of cancer is also positively influencing the global market.
Additionally, the growing use of the product in animal feed to maintain metabolism rates in livestock is further catalyzing the market growth. Besides this, the elevating product utilization to enhance the recovery of intestinal epithelial cells that boost the immunity system and the expanding need for ribonucleotides to manufacture infant food formulations are expected to propel the nucleotides market in the coming years.
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
CJ CheilJedang Corporation, Exotic Biosolutions, F. Hoffmann-La Roche AG, Jena Bioscience GmbH, Koninklijke DSM N.V., Lallemand Inc., Meridian Bioscience Inc., Nanjing Biotogether Co. Ltd., Ohly GmbH (Associated British Foods plc), Promega Corporation, Starlake Bioscience Co. Inc. and Thermo Fisher Scientific Inc
The report has been segmented the market into following categories:
Breakup by Type:
- Food Grade
- Lab Grade
- Industry Grade
- Others
Breakup by Technology:
- TaqMan Allelic Discrimination
- Gene Chips and Microarrays
- SNP by Pyrosequencing
- Others
Breakup by Form:
- Liquid
- Powder
Breakup by Application:
- Pharmaceutical
- Food and Animal Feed Additives
- Drug Discovery
- Others
Regional Insights:
- Asia Pacific
- North America
- Europe
- Middle East and Africa
- Latin America
On the geographical front, Asia Pacific enjoys the leading position in the market. This can be attributed to the rising establishment of international companies in the region, on account of low manufacturing costs and cheap labor.
Ask An Analyst: https://www.imarcgroup.com/request?type=report&id=6472&flag=C
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 |
Africa and Europe :- +44-702-409-7331 |
Asia: +91-120-433-0800, +91-120-433-0800